{"id":"NCT03337490","sponsor":"Mayne Pharma International Pty Ltd","briefTitle":"A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice","officialTitle":"A Randomized, Multi-Center, Double-blind, Placebo Controlled, Parallel Group Trial to Evaluate Efficacy and Safety of Mayne Pharma's Ivermectin 0.5% Lotion Compared to SkliceÂ® Ivermectin 0.5% Lotion in the Treatment of Head Lice","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-02","primaryCompletion":"2017-12-04","completion":"2017-12-18","firstPosted":"2017-11-09","resultsPosted":"2020-09-17","lastUpdate":"2020-09-17"},"enrollment":296,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Head Lice"],"interventions":[{"type":"DRUG","name":"Ivermectin 0.5% Topical Application Lotion","otherNames":[]},{"type":"DRUG","name":"Ivermectin 0.5% Topical Application Lotion [SKLICE]","otherNames":[]},{"type":"DRUG","name":"Placebo 0% Lotion","otherNames":[]}],"arms":[{"label":"Ivermectin 0.5% Lotion","type":"EXPERIMENTAL"},{"label":"Ivermectin 0.5% Lotion [SKLICE]","type":"ACTIVE_COMPARATOR"},{"label":"Placebo 0% Lotion","type":"PLACEBO_COMPARATOR"}],"summary":"This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.","primaryOutcome":{"measure":"The Proportion of Index Subjects Who Are Lice Free at Day 15","timeFrame":"15 Days","effectByArm":[{"arm":"Ivermectin 0.5% Lotion","deltaMin":106,"sd":null},{"arm":"Ivermectin 0.5% Lotion [SKLICE]","deltaMin":98,"sd":null},{"arm":"Placebo 0% Lotion","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":128},"commonTop":["Influenza","Pyrexia","Upper Resporitory Tract Infection","Cough"]}}